Fibro Adipose Vascular Anomaly: A Rare and Often Misdiagnosed Entity

Abstract

Fibro adipose vascular anomaly (FAVA) is a rare type of vascular malformation with distinct clinical features. The authors here discussed the clinical, imaging, differential diagnosis, histopathological features, and treatment options of FAVA along with an illustrative case. It is important to know about this uncommon entity as this can be misdiagnosed due to the overlapping clinical features with other common entities. It is a benign condition with no proven malignant potential. There are no guidelines regarding the best treatment option.

Keywords

fibro adipose vascular anomaly - vascular malformation - venous malformation

Declaration of Patient Consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial Support and Sponsorship

None.

Source(s) of Support

None.

Presentation at a Meeting

None.

Organization

Place

Date

Publication History

Article published online:
13 November 2021

• References

• 1 Merrow AC, Gupta A, Patel MN, Adams DM. 2014 revised classification of vascular lesions from the International Society for the study of vascular anomalies: Radiologic-pathologic update. Radiographics 2016; 36 (05) 1494-1516
• 2 Available at. https://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf
• 3 Alomari AI, Spencer SA, Arnold RW. et al. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop 2014; 34 (01) 109-117
• 4 Fernandez-Pineda I, Marcilla D, Downey-Carmona FJ, Roldan S, Ortega-Laureano L, Bernabeu-Wittel J. Lower extremity fibro-adipose vascular anomaly (FAVA): a new case of a newly delineated disorder. Ann Vasc Dis 2014; 7 (03) 316-319
• 5 Klemme WR, James P, Skinner SR. Latent onset unilateral toe-walking secondary to hemangioma of the gastrocnemius. J Pediatr Orthop 1994; 14 (06) 773-775
• 6 Umehara F, Matsuura E, Kitajima S, Osame M. Unilateral toe-walking secondary to intramuscular hemangioma in the gastrocnemius. Neurology 2005; 65 (07) E15
• 7 Clarke RC, Wenger RJJ. Equinus deformity and haemangioma of calf muscle. BMJ 1975;3(5978)
• 8 Shaikh R, Alomari AI, Kerr CL, Miller P, Spencer SA. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol 2016; 46 (08) 1179-1186
• 9 Erickson J, McAuliffe W, Blennerhassett L, Halbert A. Fibroadipose vascular anomaly treated with sirolimus: successful outcome in two patients. Pediatr Dermatol 2017; 34 (06) e317-e320
• 10 Ramaswamy RS, Tiwari T, Darcy MD. et al. Cryoablation of low-flow vascular malformations. Diagn Interv Radiol 2019; 25 (03) 225-230
• 11 Cheung K, Taghinia AH, Sood RF. et al. Fibroadipose vascular anomaly in the upper extremity: a distinct entity with characteristic clinical, radiological, and histopathological findings. J Hand Surg Am 2020; 45 (01) 68.e1-68.e13
• 12 Amarneh M, Shaikh R. Clinical and imaging features in fibro-adipose vascular anomaly (FAVA). Pediatr Radiol 2020; 50 (03) 380-387
• 13 López S, Ibarra A, Baselga E. et al. Fibro-adipose vascular malformation (FAVA) in forearm: a successful surgical approach and literature review. Eur J Plast Surg 2020; 43: 495-500
• 14 Wang KK, Glenn RL, Adams DM. et al. Surgical management of fibroadipose vascular anomaly of the lower extremities. J Pediatr Orthop 2020; 40 (03) e227-e236
• 15 Ferreira J, López Gutiérrez JC, Carneiro A. et al. Lower extremity fibro-adipose vascular anomaly—case report. Ann Vasc Surg 2020; 66: 671.e15-671.e18
• 16 Luks VL, Kamitaki N, Vivero MP. et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166 (04) 1048-54.e1 , 5
• 17 Keppler-Noreuil KM, Rios JJ, Parker VER. et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A [phone]